Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: Individualized Homoeopathic Intervention LM VS Centesimal Potency: Group A- Experimental
Group (LM+Topical
Placebo)
Group B - Experimental
Group (CM +Topical
Placebo)
Control Intervent
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: Patients not on antifungal medications for at least two weeks prior to the study. Willingness to participate and must provide informed consent. Patients with tinea cruris confirmed clinically and also through Investigation will be included in the study.
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to homeopathic medicines. Patients currently undergoing conventional treatment for Tinea Cruris. Other type of Tinea eg. T. Corporis, T. Pedis, T.Capitis,T.Unguium etc. Pregnant or breast feeding women. Patients with immunocompromising conditions (e.g., diabetes, HIV). Those with secondary skin infections or systemic conditions. Cases with complication like lichenification and eczema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| aim of our study is to evaluate effectiveness of LM VS Centesimal potency and topical application in the management of tinea cruris via individualized homoeopathic medicine. Timepoint: The study will be undertaken for a period of 18 months out of which cases will be registered in first 12 month so that minimum six visits/ observations can be obtained from the last case. | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactPuneet R Shah
Swasthya kalyan Homoeopathic Medical College and Research centre Jaipur Rajasthan
Outcome results
None listed